{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:25:47Z","timestamp":1792099547809,"version":"4.4.0"},"reference-count":165,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:sec id=\"ab-irv250002-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The prevalence of metabolic dysfunction\u2013associated steatotic liver disease (MASLD) in the US is highest among Hispanic\/Latino individuals. Their risk of developing metabolic dysfunction\u2013associated steatohepatitis (MASH) with fibrosis, cirrhosis with progression to hepatocellular carcinoma and need for liver transplant, and death is similarly elevated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-irv250002-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>The Hispanic\/Latino population is the fastest-growing ethnic group in the US, and their annual increase in MASLD prevalence outpaces other ethnic groups. Cardiometabolic and genetic risk factors are highly prevalent among Hispanic\/Latino persons and are closely linked to the development of MASLD. Food insecurity, limited access to health care, language barriers, and low health literacy also contribute to the risk of MASLD or progressing to MASH and cirrhosis. Culturally tailored interventions may improve individual outcomes. Screening for chronic and advanced liver disease due to MASLD can be done in high-risk patients using the Fibrosis-4 Index (FIB-4), although several studies suggest current thresholds may be insufficiently sensitive for Hispanic\/Latino patients. US Food and Drug Administration\u2013approved liver-directed pharmacologic therapy for MASH should be considered alongside management of cardiometabolic risk factors, as outlined in a proposed pathway incorporating new FIB-4 and secondary assessment thresholds for Hispanic\/Latino patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-irv250002-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The prevalence of MASLD and MASH among Hispanic\/Latino persons in the US is a significant public health challenge. Addressing this issue requires multifaceted, culturally mindful strategies that target disparities in nutrition, physical activity, genetics, research, and social determinants of health. Clinicians should incorporate routine FIB-4 risk stratification for MASLD in Hispanic\/Latino patients with cardiometabolic risk factors to enable early detection and intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamainternmed.2025.4769","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T15:30:42Z","timestamp":1758555042000},"page":"1376","source":"Crossref","is-referenced-by-count":22,"title":["Targeting MASLD and MASH in the US Hispanic\/Latino Population"],"prefix":"10.1001","volume":"185","author":[{"given":"Nicholas A.","family":"Cumpian","sequence":"first","affiliation":[{"name":"Department of Medicine, Harbor-UCLA Medical Center, Torrance, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio A.","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Center for Organ Transplant, Scripps Clinic, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Surgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy","family":"Saab","sequence":"additional","affiliation":[{"name":"Department of Surgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles"},{"name":"Department of Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"irv250002r1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature.","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"irv250002r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease.","volume":"65","author":"Rinella","year":"2024","journal-title":"J Lipid Res"},{"issue":"5","key":"irv250002r3","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"irv250002r4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review.","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"issue":"9","key":"irv250002r5","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","article-title":"Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals.","volume":"107","author":"Chan","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"irv250002r6","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis.","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"irv250002r7","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","article-title":"Natural history and progression of metabolic dysfunction-associated steatotic liver disease.","volume":"9","author":"Hagstr\u00f6m","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"irv250002r8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications.","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"issue":"11","key":"irv250002r9","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.3390\/biomedicines11113096","article-title":"The outcomes of liver transplantation in severe metabolic dysfunction-associated steatotic liver disease patients.","volume":"11","author":"Paklar","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"irv250002r10","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000352","article-title":"The changing epidemiology of adult liver transplantation in the United States in 2013-2022: the dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease.","volume":"8","author":"Younossi","year":"2023","journal-title":"Hepatol Commun"},{"issue":"2","key":"irv250002r11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ueg2.12525","article-title":"Therapeutic management of metabolic dysfunction associated steatotic liver disease.","volume":"12","author":"Zeng","year":"2024","journal-title":"United European Gastroenterol J"},{"issue":"4","key":"irv250002r13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates.","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"irv250002r14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40985-016-0043-2","article-title":"Hispanic health in the USA: a scoping review of the literature.","volume":"37","author":"Velasco-Mondragon","year":"2016","journal-title":"Public Health Rev"},{"issue":"3","key":"irv250002r15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10903-013-9773-0","article-title":"Characterization of the Hispanic or Latino population in health research: a systematic review.","volume":"16","author":"Aragones","year":"2014","journal-title":"J Immigr Minor Health"},{"issue":"12","key":"irv250002r17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11892-015-0674-6","article-title":"Epidemiology of NAFLD and type 2 diabetes: health disparities among persons of Hispanic origin.","volume":"15","author":"Lazo","year":"2015","journal-title":"Curr Diab Rep"},{"issue":"2","key":"irv250002r18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis.","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"irv250002r19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.cgh.2011.04.027","article-title":"Chronic liver disease in the Hispanic population of the United States.","volume":"9","author":"Carrion","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"irv250002r20","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/HEP.0000000000000604","article-title":"National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature.","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"issue":"2","key":"irv250002r21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cld.2015.10.005","article-title":"The prevalence and pathobiology of nonalcoholic fatty liver disease in patients of different races or ethnicities.","volume":"20","author":"Kalia","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"6","key":"irv250002r22","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/liv.15880","article-title":"Disparities among ethnic groups in mortality and outcomes among adults with MASLD: a multicenter study.","volume":"44","author":"Aboona","year":"2024","journal-title":"Liver Int"},{"issue":"1","key":"irv250002r23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s10620-024-08722-0","article-title":"Disparities in metabolic dysfunction-associated steatotic liver disease prevalence, diagnosis, treatment, and outcomes: a narrative review.","volume":"70","author":"Miller","year":"2025","journal-title":"Dig Dis Sci"},{"issue":"9","key":"irv250002r24","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1007\/s10620-024-08540-4","article-title":"Sex and race-ethnic disparities in metabolic dysfunction-associated steatotic liver disease: an analysis of 40,166 individuals.","volume":"69","author":"Fu","year":"2024","journal-title":"Dig Dis Sci"},{"issue":"4","key":"irv250002r25","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3350\/cmh.2023.0205","article-title":"Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: a longitudinal real-world study.","volume":"29","author":"Nguyen","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"irv250002r26","doi-asserted-by":"publisher","first-page":"886","DOI":"10.4239\/wjd.v15.i5.886","article-title":"Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease\/steatohepatitis and type 2 diabetes: large cohort study.","volume":"15","author":"Gosnell","year":"2024","journal-title":"World J Diabetes"},{"issue":"11","key":"irv250002r27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/LVT.0000000000000148","article-title":"Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US.","volume":"29","author":"Lim","year":"2023","journal-title":"Liver Transpl"},{"issue":"12","key":"irv250002r29","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000324","article-title":"Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States.","volume":"7","author":"Ochoa-Allemant","year":"2023","journal-title":"Hepatol Commun"},{"issue":"5","key":"irv250002r30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41575-021-00446-0","article-title":"Examining the prevalence of NAFLD and NASH in a US cohort.","volume":"18","author":"Ray","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"irv250002r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2023.101154","article-title":"Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: an updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018.","volume":"29","author":"Wang","year":"2024","journal-title":"Ann Hepatol"},{"issue":"4","key":"irv250002r32","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s10620-022-07707-1","article-title":"Prepandemic prevalence estimates of fatty liver disease and fibrosis defined by liver elastography in the United States.","volume":"68","author":"Unalp-Arida","year":"2023","journal-title":"Dig Dis Sci"},{"issue":"2","key":"irv250002r33","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/j.jhep.2023.08.019","article-title":"Prevalence of steatotic liver disease and associated fibrosis in the United States: results from NHANES 2017-March 2020.","volume":"80","author":"Luo","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"irv250002r34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cgh.2021.12.029","article-title":"Prevalence of high-risk nonalcoholic steatohepatitis (NASH) in the United States: results from NHANES 2017-2018.","volume":"21","author":"Vilar-Gomez","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"irv250002r35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s43856-024-00649-x","article-title":"Disparities in steatosis prevalence in the United States by race or ethnicity according to the 2023 criteria.","volume":"4","author":"D\u00edaz","year":"2024","journal-title":"Commun Med (Lond)"},{"issue":"2","key":"irv250002r36","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cgh.2024.06.038","article-title":"Disparities for Hispanic adults with metabolic dysfunction-associated steatotic liver disease in the United States: a systematic review and meta-analysis.","volume":"23","author":"Tesfai","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"17","key":"irv250002r37","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.3748\/wjg.v20.i17.4987","article-title":"NAFLD prevalence differs among Hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis.","volume":"20","author":"Fleischman","year":"2014","journal-title":"World J Gastroenterol"},{"key":"irv250002r38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20517\/mtod.2023.45","article-title":"Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease.","volume":"4","author":"Gulati","year":"2024","journal-title":"Metab Target Organ Damage"},{"issue":"3","key":"irv250002r39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cgh.2014.08.037","article-title":"Prevalence of suspected nonalcoholic fatty liver disease in Hispanic\/Latino individuals differs by heritage.","volume":"13","author":"Kallwitz","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"irv250002r40","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/gutjnl-2023-331003","article-title":"Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease.","volume":"73","author":"Lee","year":"2024","journal-title":"Gut"},{"issue":"3","key":"irv250002r41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s13679-019-00349-x","article-title":"Ethnic disparities in adiposity: focus on non-alcoholic fatty liver disease, visceral, and generalized obesity.","volume":"8","author":"Agbim","year":"2019","journal-title":"Curr Obes Rep"},{"issue":"47","key":"irv250002r42","doi-asserted-by":"publisher","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"20","key":"irv250002r43","doi-asserted-by":"publisher","first-page":"15473","DOI":"10.3390\/ijms242015473","article-title":"Metabolic-dysfunction-associated steatotic liver disease-its pathophysiology, association with atherosclerosis and cardiovascular disease, and treatments.","volume":"24","author":"Yanai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"irv250002r44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease.","volume":"122","author":"Lekakis","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"1","key":"irv250002r45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7570\/jomes22021","article-title":"Recent epidemiology and risk factors of nonalcoholic fatty liver disease.","volume":"31","author":"Huh","year":"2022","journal-title":"J Obes Metab Syndr"},{"issue":"1","key":"irv250002r46","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"irv250002r49","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.2337\/dc13-2939","article-title":"Prevalence of diabetes among Hispanics\/Latinos from diverse backgrounds: the Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL).","volume":"37","author":"Schneiderman","year":"2014","journal-title":"Diabetes Care"},{"issue":"12","key":"irv250002r51","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.2337\/dc19-0532","article-title":"Racial\/ethnic disparities in the prevalence of diabetes and prediabetes by BMI: Patient Outcomes Research To Advance Learning (PORTAL) multisite cohort of adults in the U.S.","volume":"42","author":"Zhu","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"irv250002r56","doi-asserted-by":"publisher","first-page":"19475","DOI":"10.1038\/s41598-022-21878-x","article-title":"Racial disparities and prevalence of cardiovascular disease risk factors, cardiometabolic risk factors, and cardiovascular health metrics among US adults: NHANES 2011-2018.","volume":"12","author":"Lopez-Neyman","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"irv250002r57","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2337\/dc20-1997","article-title":"Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening.","volume":"44","author":"Lomonaco","year":"2021","journal-title":"Diabetes Care"},{"issue":"1","key":"irv250002r58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/dsi23-0015","article-title":"Nonalcoholic fatty liver disease in diabetes: a call to action.","volume":"37","author":"Cusi","year":"2024","journal-title":"Diabetes Spectr"},{"issue":"2","key":"irv250002r59","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jhep.2021.02.034","article-title":"Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.","volume":"75","author":"Harrison","year":"2021","journal-title":"J Hepatol"},{"issue":"47","key":"irv250002r60","doi-asserted-by":"publisher","first-page":"48968","DOI":"10.1074\/jbc.M407841200","article-title":"Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.","volume":"279","author":"Jenkins","year":"2004","journal-title":"J Biol Chem"},{"issue":"12","key":"irv250002r61","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"issue":"7","key":"irv250002r62","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00439-012-1141-y","article-title":"A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease.","volume":"131","author":"Zain","year":"2012","journal-title":"Hum Genet"},{"issue":"8","key":"irv250002r63","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1111\/liv.15946","article-title":"Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity.","volume":"44","author":"Schenker","year":"2024","journal-title":"Liver Int"},{"issue":"6","key":"irv250002r64","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jhep.2020.01.029","article-title":"A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.","volume":"72","author":"Walker","year":"2020","journal-title":"J Hepatol"},{"issue":"11","key":"irv250002r65","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.cgh.2019.02.007","article-title":"American ancestry is a risk factor for suspected nonalcoholic fatty liver disease in Hispanic\/Latino adults.","volume":"17","author":"Kallwitz","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"irv250002r66","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1007\/s11033-014-3341-0","article-title":"PNPLA3 I148M polymorphism is associated with elevated alanine transaminase levels in Mexican Indigenous and Mestizo populations.","volume":"41","author":"Larrieta-Carrasco","year":"2014","journal-title":"Mol Biol Rep"},{"issue":"2","key":"irv250002r69","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1172\/JCI92407","article-title":"Out of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease.","volume":"127","author":"Parks","year":"2017","journal-title":"J Clin Invest"},{"issue":"7","key":"irv250002r70","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease.","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"irv250002r71","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-075179","article-title":"Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention.","volume":"383","author":"Romero-G\u00f3mez","year":"2023","journal-title":"BMJ"},{"issue":"23","key":"irv250002r72","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.3390\/nu15234997","article-title":"Adherence to a traditional Mexican diet is associated with lower hepatic steatosis in US-born Hispanics of Mexican descent with overweight or obesity.","volume":"15","author":"Lopez-Pentecost","year":"2023","journal-title":"Nutrients"},{"issue":"10","key":"irv250002r73","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1111\/liv.15024","article-title":"Diet and exercise in NAFLD\/NASH: beyond the obvious.","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int"},{"issue":"10","key":"irv250002r74","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jand.2018.10.011","article-title":"The association between food insecurity and diet quality varies by race\/ethnicity: an analysis of National Health and Nutrition Examination Survey 2011-2014 results.","volume":"119","author":"Leung","year":"2019","journal-title":"J Acad Nutr Diet"},{"issue":"1","key":"irv250002r76","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/jn\/nxz212","article-title":"Food insecurity may be an independent risk factor associated with nonalcoholic fatty liver disease among low-income adults in the United States.","volume":"150","author":"Golovaty","year":"2020","journal-title":"J Nutr"},{"issue":"9","key":"irv250002r78","doi-asserted-by":"publisher","first-page":"204","DOI":"10.15585\/mmwr.mm7309a3","article-title":"Racial and ethnic differences in social determinants of health and health-related social needs among adults - Behavioral Risk Factor Surveillance System, United States, 2022.","volume":"73","author":"Town","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"irv250002r79","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2105\/AJPH.2015.302580","article-title":"The Supplemental Nutrition Assistance Program, food insecurity, dietary quality, and obesity among U.S. adults.","volume":"105","author":"Nguyen","year":"2015","journal-title":"Am J Public Health"},{"issue":"1","key":"irv250002r80","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s13668-016-0153-y","article-title":"The relationship between food insecurity, dietary patterns, and obesity.","volume":"5","author":"Morales","year":"2016","journal-title":"Curr Nutr Rep"},{"issue":"6","key":"irv250002r81","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3945\/ajcn.113.082685","article-title":"Food-group and nutrient-density intakes by Hispanic and Latino backgrounds in the Hispanic Community Health Study\/Study of Latinos.","volume":"99","author":"Siega-Riz","year":"2014","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"irv250002r82","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/oby.23638","article-title":"Obesity among Latinx people in the United States: a review.","volume":"31","author":"Alem\u00e1n","year":"2023","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"irv250002r83","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s10903-023-01552-8","article-title":"Racial, ethnic, and immigrant generational disparities in physically strenuous and hazardous work conditions.","volume":"26","author":"Abarca Nava","year":"2024","journal-title":"J Immigr Minor Health"},{"issue":"3","key":"irv250002r84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247804","article-title":"Trajectories of physical functioning among older adults in the US by race, ethnicity and nativity: examining the role of working conditions.","volume":"16","author":"Pebley","year":"2021","journal-title":"PLoS One"},{"key":"irv250002r85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2021.100990","article-title":"Physical work conditions and disparities in later life functioning: potential pathways.","volume":"16","author":"Andrasfay","year":"2021","journal-title":"SSM Popul Health"},{"issue":"3","key":"irv250002r86","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3390\/ijerph18031302","article-title":"Diet quality and eating practices among Hispanic\/Latino Men and Women: NHANES 2011-2016.","volume":"18","author":"Overcash","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"9-10","key":"irv250002r88","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s00508-023-02314-0","article-title":"Association of physical activity with MAFLD\/MASLD and LF among adults in NHANES, 2017-2020.","volume":"136","author":"Li","year":"2024","journal-title":"Wien Klin Wochenschr"},{"issue":"3","key":"irv250002r89","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1210\/clinem\/dgab795","article-title":"The effect of high-intensity interval training vs moderate-intensity continuous training on liver fat: a systematic review and meta-analysis.","volume":"107","author":"Sabag","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"irv250002r90","doi-asserted-by":"publisher","first-page":"267","DOI":"10.17161\/kjm.vol15.17592","article-title":"Racial\/ethnic disparities and determinants of sufficient physical activity levels.","volume":"15","author":"Patel","year":"2022","journal-title":"Kans J Med"},{"issue":"7","key":"irv250002r91","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1123\/jpah.8.7.916","article-title":"Perceived barriers to exercise in Hispanic adults by level of activity.","volume":"8","author":"Bautista","year":"2011","journal-title":"J Phys Act Health"},{"key":"irv250002r92","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.landurbplan.2014.01.017","article-title":"Urban green space, public health, and environmental justice: the challenge of making cities \u201cjust green enough.\u201d","volume":"125","author":"Wolch","year":"2014","journal-title":"Landsc Urban Plan"},{"issue":"2","key":"irv250002r93","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.amepre.2004.10.027","article-title":"Contributions of leisure studies and recreation and park management research to the active living agenda.","volume":"28","author":"Godbey","year":"2005","journal-title":"Am J Prev Med"},{"issue":"2","key":"irv250002r94","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10900-011-9471-6","article-title":"Demographic characteristics and physical activity behaviors in sixteen Michigan parks.","volume":"37","author":"Reed","year":"2012","journal-title":"J Community Health"},{"issue":"5","key":"irv250002r95","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.3390\/ijerph18052563","article-title":"Green space and health equity: a systematic review on the potential of green space to reduce health disparities.","volume":"18","author":"Rigolon","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"irv250002r96","doi-asserted-by":"publisher","first-page":"802","DOI":"10.5993\/AJHB.43.4.13","article-title":"Neighborhood walkability and aerobic physical activity among Latinos.","volume":"43","author":"Murillo","year":"2019","journal-title":"Am J Health Behav"},{"issue":"3","key":"irv250002r97","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1123\/jpah.10.3.335","article-title":"Built environment associations with health behaviors among Hispanics.","volume":"10","author":"Fields","year":"2013","journal-title":"J Phys Act Health"},{"issue":"2","key":"irv250002r98","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2217\/WHE.13.9","article-title":"Physical activity in Latinas: social and environmental influences.","volume":"9","author":"Larsen","year":"2013","journal-title":"Womens Health (Lond)"},{"key":"irv250002r99","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.pmedr.2015.09.001","article-title":"Active living environment assessments in four rural Latino communities.","volume":"2","author":"Perry","year":"2015","journal-title":"Prev Med Rep"},{"issue":"1","key":"irv250002r100","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/08901171211022677","article-title":"The neighborhood environment and Hispanic\/Latino health.","volume":"36","author":"Heredia","year":"2022","journal-title":"Am J Health Promot"},{"issue":"6","key":"irv250002r102","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/1358863X231191546","article-title":"Examining health care access disparities in Hispanic populations with peripheral artery disease and diabetes.","volume":"28","author":"Bazikian","year":"2023","journal-title":"Vasc Med"},{"issue":"12","key":"irv250002r104","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.4182","article-title":"Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US.","volume":"2","author":"Eberly","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"2","key":"irv250002r105","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1177\/1077558703254101","article-title":"Sicker and poorer\u2014the consequences of being uninsured: a review of the research on the relationship between health insurance, medical care use, health, work, and income.","volume":"60","author":"Hadley","year":"2003","journal-title":"Med Care Res Rev"},{"issue":"1","key":"irv250002r107","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.2337\/dc25-SREV","article-title":"Summary of revisions: standards of care in diabetes\u20142025.","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care"},{"issue":"2","key":"irv250002r108","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20294","article-title":"Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014-2019.","volume":"3","author":"Wong","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"irv250002r109","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2024.100609","article-title":"A comprehensive assessment of liver transplant trends and outcomes among adults with steatotic liver disease in the U.S.","volume":"4","author":"Patel","year":"2024","journal-title":"Gastro Hep Adv"},{"issue":"2","key":"irv250002r111","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/lt.25936","article-title":"Impact of payer status on delisting among liver transplant candidates in the United States.","volume":"27","author":"Karunungan","year":"2021","journal-title":"Liver Transpl"},{"issue":"3","key":"irv250002r113","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jamainternmed.2019.6282","article-title":"Characteristics of Americans with primary care and changes over time, 2002-2015.","volume":"180","author":"Levine","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"irv250002r114","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3122\/jabfm.2022.01.210253","article-title":"Community-based health care navigation\u2019s impact on access to primary care for low-income Latinos.","volume":"35","author":"Saluja","year":"2022","journal-title":"J Am Board Fam Med"},{"issue":"10","key":"irv250002r115","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1377\/hlthaff.2016.0455","article-title":"Insurance churning rates for low-income adults under health reform: lower than expected but still harmful for many.","volume":"35","author":"Sommers","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"5","key":"irv250002r116","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1007\/s11606-022-07995-3","article-title":"Barriers in healthcare for Latinx patients with limited English proficiency\u2014a narrative review.","volume":"38","author":"Escobedo","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"6","key":"irv250002r117","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1475-6773.2009.01017.x","article-title":"Mistrust of health care organizations is associated with underutilization of health services.","volume":"44","author":"LaVeist","year":"2009","journal-title":"Health Serv Res"},{"issue":"3","key":"irv250002r118","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/jamainternmed.2016.8648","article-title":"Association of patient-physician language concordance and glycemic control for limited-English proficiency Latinos with type 2 diabetes.","volume":"177","author":"Parker","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"5","key":"irv250002r119","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD).","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"issue":"8","key":"irv250002r120","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jama.2021.12531","article-title":"Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force Recommendation Statement.","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"irv250002r121","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1053\/j.gastro.2023.06.013","article-title":"AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review.","volume":"165","author":"Wattacheril","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"irv250002r122","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cgh.2022.01.015","article-title":"Performance of noninvasive tests of fibrosis among Asians, Hispanic, and non-Hispanic Whites in the STELLAR trials.","volume":"21","author":"Wong","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"irv250002r123","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1097\/HEP.0000000000001121","article-title":"Disparities in screening and risk stratification for Hispanic adults with metabolic dysfunction-associated steatotic liver disease.","volume":"81","author":"Tincopa","year":"2025","journal-title":"Hepatology"},{"issue":"6","key":"irv250002r124","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis.","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"irv250002r125","doi-asserted-by":"publisher","DOI":"10.1038\/s44355-024-00017-5","article-title":"Reviewing MAESTRO-NASH and the implications for hepatology and health systems in implementation\/accessibility of resmetirom.","author":"Brennan","journal-title":"npj Gut Liver"},{"issue":"11-12","key":"irv250002r126","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1111\/apt.18331","article-title":"Semaglutide 2.4?mg in participants with metabolic dysfunction-associated steatohepatitis: baseline characteristics and design of the phase 3 ESSENCE trial.","volume":"60","author":"Newsome","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"irv250002r127","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/tgh-23-62","article-title":"Lower FIB-4 threshold in patients with diabetes improves diagnostic accuracy of the test in a Hispanic population.","volume":"9","author":"Singh","year":"2024","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"12","key":"irv250002r128","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.cgh.2024.07.003","article-title":"Expert panel recommendations: practical clinical applications for initiating and monitoring resmetirom in patients with MASH\/NASH and moderate to noncirrhotic advanced fibrosis.","volume":"22","author":"Noureddin","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"irv250002r129","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jhep.2021.12.031","article-title":"Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events.","volume":"76","author":"Boursier","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"irv250002r130","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jhep.2022.06.016","article-title":"Low accuracy of FIB-4 test to identify people with diabetes at low risk of advanced fibrosis.","volume":"77","author":"Gracen","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"irv250002r131","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jhep.2019.12.025","article-title":"FIB-4 cut-off of 1.3 may be inappropriate in a primary care referral pathway for patients with non-alcoholic fatty liver disease.","volume":"73","author":"Shah","year":"2020","journal-title":"J Hepatol"},{"issue":"9","key":"irv250002r133","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2105\/AJPH.2018.304542","article-title":"Community health workers, access to care, and service utilization among Florida Latinos: a randomized controlled trial.","volume":"108","author":"Chang","year":"2018","journal-title":"Am J Public Health"},{"issue":"10","key":"irv250002r134","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jama.1996.03530340047028","article-title":"Use and effectiveness of interpreters in an emergency department.","volume":"275","author":"Baker","year":"1996","journal-title":"JAMA"},{"issue":"4","key":"irv250002r135","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2337\/dc10-1981","article-title":"Randomized trial of a literacy-sensitive, culturally tailored diabetes self-management intervention for low-income Latinos: Latinos en control.","volume":"34","author":"Rosal","year":"2011","journal-title":"Diabetes Care"},{"issue":"12","key":"irv250002r136","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.27744","article-title":"Effect of a culturally adapted behavioral intervention for Latino adults on weight loss over 2 years: a randomized clinical trial.","volume":"3","author":"Rosas","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"irv250002r137","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/15404153211043885","article-title":"Perceived barriers to weight loss among Hispanic patients with non-alcoholic fatty liver disease.","volume":"20","author":"Heredia","year":"2022","journal-title":"Hisp Health Care Int"},{"issue":"1","key":"irv250002r138","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/FCH.0000000000000311","article-title":"Latino health access: comparative effectiveness of a community-initiated promotor\/a-led diabetes self-management education program.","volume":"45","author":"Slater","year":"2022","journal-title":"Fam Community Health"},{"issue":"11","key":"irv250002r139","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jama.2018.13022","article-title":"Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force Recommendation Statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"11","key":"irv250002r140","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"irv250002r141","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2023.102216","article-title":"Healthcare provider-delivered healthy eating recommendations among U.S. Hispanic\/Latino adults.","volume":"33","author":"Castro","year":"2023","journal-title":"Prev Med Rep"},{"issue":"5","key":"irv250002r142","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/advances\/nmab039","article-title":"Healthy food prescription programs and their impact on dietary behavior and cardiometabolic risk factors: a systematic review and meta-analysis.","volume":"12","author":"Bhat","year":"2021","journal-title":"Adv Nutr"},{"key":"irv250002r144","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/ajae\/aax026","article-title":"Partial identification methods for evaluating food assistance programs: a case study of the causal impact of SNAP on food insecurity.","volume":"99","author":"Gundersen","year":"2017","journal-title":"Am J Agric Econ"},{"issue":"2","key":"irv250002r145","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3945\/jn.114.198697","article-title":"Supplemental Nutrition Assistance Program participation is associated with an increase in household food security in a national evaluation.","volume":"145","author":"Mabli","year":"2015","journal-title":"J Nutr"},{"key":"irv250002r147","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2023.116141","article-title":"County- and state-level immigration policies are associated with Supplemental Nutrition Assistance Program (SNAP) participation among Latino households.","volume":"333","author":"Chaparro","year":"2023","journal-title":"Soc Sci Med"},{"issue":"9","key":"irv250002r148","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1017\/S1368980023000885","article-title":"The association between language use and food insecurity among Hispanic adults residing in the USA depends on nativity.","volume":"26","author":"Lopez","year":"2023","journal-title":"Public Health Nutr"},{"issue":"1","key":"irv250002r150","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40795-025-01089-z","article-title":"Developing and evaluating a culturally-appropriate food kit for increased access to fruits and vegetables and DASH eating plan alignment in immigrant Hispanic\/Latine individuals with hypertension: a pilot study.","volume":"11","author":"Crusan","year":"2025","journal-title":"BMC Nutr"},{"key":"irv250002r151","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1269390","article-title":"Lessons learned by adapting and implementing LUCHA: a deep-structure culturally tailored healthy eating randomized pilot intervention for ethnic-diverse Latinos.","volume":"11","author":"Mattei","year":"2024","journal-title":"Front Public Health"},{"key":"irv250002r152","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106954","article-title":"Linking churches and parks to promote physical activity among Latinos: rationale and design of the Parishes & Parks cluster randomized trial.","volume":"123","author":"Derose","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"irv250002r153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2021.100975","article-title":"Socioeconomic and racial disparities of sidewalk quality in a traditional rust belt city.","volume":"16","author":"Rajaee","year":"2021","journal-title":"SSM Popul Health"},{"issue":"1","key":"irv250002r155","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3122\/jabfm.2017.01.160208","article-title":"Impact of the Affordable Care Act on health care access and utilization among Latinos.","volume":"30","author":"Alcal\u00e1","year":"2017","journal-title":"J Am Board Fam Med"},{"issue":"3","key":"irv250002r156","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/1540415317727569","article-title":"Using CBPR to decrease health disparities in a suburban Latino neighborhood.","volume":"15","author":"Coffman","year":"2017","journal-title":"Hisp Health Care Int"},{"issue":"3","key":"irv250002r157","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/10901981221090161","article-title":"Effectiveness of a Promotores network to improve health in an emerging Latino community.","volume":"49","author":"Taverno Ross","year":"2022","journal-title":"Health Educ Behav"},{"issue":"6","key":"irv250002r158","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.17004","article-title":"Effect of electronic and mail outreach from primary care physicians for COVID-19 vaccination of Black and Latino older adults: a randomized clinical trial.","volume":"5","author":"Lieu","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"irv250002r159","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cgh.2015.05.001","article-title":"Nonalcoholic fatty liver disease in Latinos.","volume":"14","author":"Saab","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"21","key":"irv250002r161","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis.","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"irv250002r162","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000860","article-title":"MASH clinical trials and drugs pipeline: an impending tsunami.","author":"Noureddin","journal-title":"Hepatology"},{"key":"irv250002r12","author":"Younossi"},{"key":"irv250002r67","author":"Sanyal","year":"2024"},{"key":"irv250002r68","author":"Chalasani","year":"2024"},{"key":"irv250002r103","volume-title":"Diabetes in America","author":"Casagrande","year":"2023"},{"key":"irv250002r106","volume-title":"Hispanics and the Future of America","author":"Escarce","year":"2006"},{"key":"irv250002r160","year":"2024"},{"key":"irv250002r16","unstructured":"US Census Bureau. Hispanic origin. Accessed June 23, 2025. https:\/\/www.census.gov\/data\/academy\/resources\/one-pagers\/hispanic-origin.html"},{"key":"irv250002r28","unstructured":"US Census Bureau. Annual estimates of the resident population by sex, race, and Hispanic origin for the United States: April 1, 2020 to July 1, 2023 (NC-EST2023-SR11H). Accessed February 2, 2025. https:\/\/www2.census.gov\/programs-surveys\/popest\/tables\/2020-2023\/national\/asrh\/nc-est2023-sr11h.xlsx"},{"key":"irv250002r47","doi-asserted-by":"crossref","unstructured":"Emmerich? SD, Fryar? CD, Stierman? B, Ogden? CL. Obesity and severe obesity prevalence in adults: United States, August 2021\u2013August 2023. Accessed January 10, 2025. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db508.htm","DOI":"10.15620\/cdc\/159281"},{"key":"irv250002r48","unstructured":"Stierman? B, Afful? J, Carroll? MD, . National Health and Nutrition Examination Survey 2017\u2013March 2020 prepandemic data files\u2014development of files and prevalence estimates for selected health outcomes. Accessed January 15, 2025. https:\/\/stacks.cdc.gov\/view\/cdc\/106273"},{"key":"irv250002r50","unstructured":"Mendola? ND, Chen? TC, Gu? Q, Eberhardt? MS, Saydah? S. Prevalence of total, diagnosed, and undiagnosed diabetes among adults: United States, 2013\u20132016. Accessed January 15, 2025. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db319.htm"},{"key":"irv250002r52","unstructured":"Carroll? MD, Fryar? CD, Gwira? JA, Iniguez? M. Total and high-density lipoprotein cholesterol in adults: United States, August 2021\u2013August 2023. Accessed January 10, 2025. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db515.htm"},{"key":"irv250002r53","unstructured":"US Centers for Disease Control and Prevention. Interactive summary health statistics for adults: percentage of coronary heart disease for adults aged 18 and over, United States, 2019-2023. Accessed December 27, 2024. https:\/\/wwwn.cdc.gov\/NHISDataQueryTool\/SHS_adult\/index.html"},{"key":"irv250002r54","unstructured":"Ostchega? Y, Fryar? CD, Nwankwo? T, Nguyen? DT. Hypertension prevalence among adults aged 18 and over: United States, 2017-2018. Accessed January 12, 2025. https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db364-h.pdf"},{"key":"irv250002r55","unstructured":"Fryar? CD, Kit? B, Carroll? MD, Afful? J, Kuo? T. Hypertension prevalence, treatment, and control among adults: Los Angeles County and the United States, 2015\u20132018. Accessed February 1, 2025. https:\/\/www.cdc.gov\/nchs\/data\/hestat\/hypertension-15-18\/hypertension-15-18.htm"},{"key":"irv250002r75","doi-asserted-by":"crossref","unstructured":"Rabbitt? MP, Reed-Jones? M, Hales? LJ, Burke? MP. Household food security in the United States in 2023. Accessed January 29, 2025. https:\/\/www.ers.usda.gov\/publications\/pub-details?pubid=109895","DOI":"10.32747\/2024.8583175.ers"},{"key":"irv250002r77","unstructured":"Ndugga? N, Hill? L, Artiga? S. Key data on health and health care by race and ethnicity. Accessed December 28, 2024. https:\/\/www.ers.usda.gov\/publications\/pub-details?pubid=109895"},{"key":"irv250002r87","unstructured":"Economic Research Service. Food Access Research Atlas. Accessed May 23, 2025. https:\/\/www.ers.usda.gov\/data-products\/food-access-research-atlas\/"},{"key":"irv250002r101","doi-asserted-by":"crossref","unstructured":"Cohen? RA, Briones? EM. Health insurance coverage: early release of quarterly estimates from the National Health Interview Survey, 2023\u2013June 2024. Accessed January 26, 2025. https:\/\/www.cdc.gov\/nchs\/data\/nhis\/earlyrelease\/Quarterly_Estimates_2024_Q12.pdf","DOI":"10.15620\/cdc\/170372"},{"key":"irv250002r110","unstructured":"Office of the Assistant Secretary for Planning and Evaluation. Health insurance coverage and access to care among Latino Americans: recent trends and key challenges. Accessed June 6, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK611353\/pdf\/Bookshelf_NBK611353.pdf"},{"key":"irv250002r112","unstructured":"Organ Procurement & Transplantation Network. National data. Accessed June 6, 2025. https:\/\/optn.transplant.hrsa.gov\/data\/view-data-reports\/national-data\/#"},{"key":"irv250002r132","unstructured":"US Preventive Services Task Force. Recommendation: statin use for the primary prevention of cardiovascular disease in adults: preventive medication. Accessed July 18, 2025. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/statin-use-in-adults-preventive-medication"},{"key":"irv250002r143","unstructured":"Shrider? EA. Poverty in the United States: 2023. Accessed June 14, 2025. https:\/\/www2.census.gov\/library\/publications\/2024\/demo\/p60-283.pdf"},{"key":"irv250002r146","unstructured":"Coleman-Jensen? A, Rabbitt? MP, Gregory? CA, Singh? A. Household food security in the United States in 2021. Accessed June 23, 2025. https:\/\/www.ers.usda.gov\/publications\/pub-details\/?pubid=104655"},{"key":"irv250002r149","unstructured":"Center on Budget and Policy Priorities. SNAP helps millions of Latinos. Accessed June 22, 2025. https:\/\/www.cbpp.org\/research\/food-assistance\/snap-helps-millions-of-latinos"},{"key":"irv250002r154","unstructured":"Ramirez? A, Aguilar? R, Merck? A, Sukumaran? P, Gamse? C. The state of Latino housing, transportation, and green space: a research review. Accessed June 14, 2025. https:\/\/salud-america.org\/the-state-of-latino-housing-transportation-greenspace-research\/"},{"key":"irv250002r163","unstructured":"A study to evaluate the efficacy and safety of pegozafermin in participants with compensated cirrhosis due to MASH. ClinicalTrials.gov identifier: NCT06419374. Updated June 5, 2025. Accessed June 8, 2025. https:\/\/clinicaltrials.gov\/study\/NCT06419374"},{"key":"irv250002r164","unstructured":"LIVERAGE\u2122 - Cirrhosis: a study to test whether survodutide helps people with a liver disease called NASH\/MASH who have cirrhosis. ClinicalTrials.gov identifier: NCT06632457. Updated June 4, 2025. Accessed June 8, 2025. https:\/\/clinicaltrials.gov\/study\/NCT06632457"},{"key":"irv250002r165","unstructured":"A study evaluating efruxifermin in subjects with non-invasively diagnosed nonalcoholic steatohepatitis (NASH)\/metabolic dysfunction-associated steatohepatitis (MASH) and nonalcoholic fatty liver disease (NAFLD)\/metabolic dysfunction-associated steatotic liver disease (MASLD). ClinicalTrials.gov identifier: NCT06161571. Updated June 5, 2025. Accessed June 8, 2025. https:\/\/clinicaltrials.gov\/study\/NCT06161571"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2839293\/jamainternal_cumpian_2025_rv_250002_1761147079.26737.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:01:12Z","timestamp":1762185672000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2839293"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":165,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2025.4769","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,1]]}}}